Double-blind drug study in depressed outpatients. 1972

J Yamamoto, and F M Kline, and R W Burgoyne

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D003975 Diazepam A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one,Apaurin,Diazemuls,Faustan,Relanium,Seduxen,Sibazon,Stesolid,Valium
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000639 Amitriptyline Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines. Amineurin,Amitrip,Amitriptylin Beta,Amitriptylin Desitin,Amitriptylin RPh,Amitriptylin-Neuraxpharm,Amitriptyline Hydrochloride,Amitrol,Anapsique,Apo-Amitriptyline,Damilen,Domical,Elavil,Endep,Laroxyl,Lentizol,Novoprotect,Saroten,Sarotex,Syneudon,Triptafen,Tryptanol,Tryptine,Tryptizol,Amitriptylin Neuraxpharm,Apo Amitriptyline,Desitin, Amitriptylin,RPh, Amitriptylin

Related Publications

J Yamamoto, and F M Kline, and R W Burgoyne
May 1997, Pharmacopsychiatry,
J Yamamoto, and F M Kline, and R W Burgoyne
December 1966, Current therapeutic research, clinical and experimental,
J Yamamoto, and F M Kline, and R W Burgoyne
February 1992, The Journal of clinical psychiatry,
J Yamamoto, and F M Kline, and R W Burgoyne
June 1995, Journal of affective disorders,
J Yamamoto, and F M Kline, and R W Burgoyne
October 1982, The Journal of clinical psychiatry,
J Yamamoto, and F M Kline, and R W Burgoyne
August 1991, The Journal of clinical psychiatry,
J Yamamoto, and F M Kline, and R W Burgoyne
January 1984, Psychopharmacology,
J Yamamoto, and F M Kline, and R W Burgoyne
January 1994, International clinical psychopharmacology,
J Yamamoto, and F M Kline, and R W Burgoyne
January 1984, Psychopharmacology bulletin,
J Yamamoto, and F M Kline, and R W Burgoyne
June 1979, The American journal of psychiatry,
Copied contents to your clipboard!